Literature DB >> 4516215

Refractory leukemia treated with cytosine arabinoside and cyclophosphamide.

B M Ansari, E N Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4516215     DOI： 10.1002/1097-0142(197308)32:2<294::aid-cncr2820320203>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  2 in total

1.  Methoxy-9-ellipticine lactate in refractory acute myeloid leukaemia.

Authors:  B M Ansari; E N Thompson
Journal:  Postgrad Med J       Date:  1975-02       Impact factor: 2.401

2.  Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].

Authors:  T S Herman; B G Durie; J J Hutter
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.